Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

CF Equities HAIG - Pharma

+ Add to Watchlist

CFEQPHB:LX

64.29 EUR 0.25 0.39%

As of 00:59:30 ET on 06/19/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for CF Equities HAIG - Pharma (CFEQPHB)

Year To Date: +6.87% 3-Month: +1.33% 3-Year: -0.97% 52-Week Range: 59.11 - 66.57
1-Month: -1.12% 1-Year: +7.28% 5-Year: +1.60% Beta vs LUXXX: 0.57

Mutual Fund Chart for CFEQPHB

No chart data available.
  • CFEQPHB:LX 64.29
  • 1M
  • 1Y
Interactive CFEQPHB Chart

Previous Close

Fund Profile & Information for CFEQPHB

CF Equities HAIG - Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve the highest possible growth with its invested capital. The Fund invests primarily in equities of companies within the health industry. Pharmaceuticals, Health Services, Biotech, and the production of drugs are all possible sectors to be invested in worldwide.

Inception Date: 08-18-1999 Telephone: Tel +352 45 13 14 500
Managers: -
Web Site: www.hua-invest.lu

Fundamentals for CFEQPHB

NAV (on 2013-06-19) 64.29
Assets (M) (on 2013-06-19) 6.99
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment -

Dividends for CFEQPHB

No dividends reported

Fees & Expenses for CFEQPHB

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.43

Top Fund Holdings for CFEQPHB

Filing Date: 04/30/2013
Name Position Value % of Total
M4E AG 200,000 570,400 8.834%
4SC AG 310,000 550,870 8.531%
Burcon NutraScience Corp 200,000 383,978 5.947%
Roche Holding AG 2,000 381,061 5.901%
US DOLLAR SPOT 467 356,207 5.516%
Merck & Co Inc 9,000 328,534 5.088%
UnitedHealth Group Inc 6,500 297,579 4.609%
Mylan Inc/PA 13,000 287,886 4.458%
Ranbaxy Laboratories Ltd 41,350 261,940 4.057%
Eli Lilly & Co 6,000 256,534 3.973%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil